These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 2570687

  • 1. Effect of maprotiline combined with conventional neuroleptics against negative symptoms of chronic schizophrenia.
    Yamagami S, Soejima K.
    Drugs Exp Clin Res; 1989; 15(4):171-6. PubMed ID: 2570687
    [Abstract] [Full Text] [Related]

  • 2. Zotepine in the treatment of negative symptoms in chronic schizophrenia.
    Fleischhacker WW, Barnas C, Stuppäck C, Unterweger B, Hinterhuber H.
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):58-60. PubMed ID: 2883684
    [Abstract] [Full Text] [Related]

  • 3. [New chemotherapy approaches to psychoses].
    Olié JP, Baylé FJ.
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [Abstract] [Full Text] [Related]

  • 4. Antidepressant drugs in anergic schizophrenia. A double-blind cross-over study with maprotiline and placebo.
    Waehrens J, Gerlach J.
    Acta Psychiatr Scand; 1980 May; 61(5):438-44. PubMed ID: 6105762
    [Abstract] [Full Text] [Related]

  • 5. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
    Meltzer HY, Sommers AA, Luchins DJ.
    J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
    [Abstract] [Full Text] [Related]

  • 6. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
    Shiloh R, Weizman A, Weizer N, Dorfman-Etrog P, Munitz H.
    Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053
    [Abstract] [Full Text] [Related]

  • 7. [Incidence of the deficit form in refractory schizophrenia].
    Samuelian JC.
    Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
    [Abstract] [Full Text] [Related]

  • 8. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
    Harvey PD, Davidson M, White L, Keefe RS, Hirschowitz J, Mohs RC, Davis KL.
    Biol Psychiatry; 1996 Oct 15; 40(8):755-60. PubMed ID: 8894068
    [Abstract] [Full Text] [Related]

  • 9. Quetiapine in schizophrenia: onset of action within the first week of treatment.
    Small JG, Kolar MC, Kellams JJ.
    Curr Med Res Opin; 2004 Jul 15; 20(7):1017-23. PubMed ID: 15265246
    [Abstract] [Full Text] [Related]

  • 10. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V, Serretti A, Mandelli L, Koprivsek J, Kastelic M, Plesnicar BK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1562-6. PubMed ID: 18573584
    [Abstract] [Full Text] [Related]

  • 11. Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine.
    Delle Chiaie R, Salviati M, Fiorentini S, Biondi M.
    Exp Clin Psychopharmacol; 2007 Dec 01; 15(6):563-8. PubMed ID: 18179309
    [Abstract] [Full Text] [Related]

  • 12. Antidepressant combination therapy of endogenous depressions with benzodiazepines or neuroleptics--a study comparing adjuvant treatment with oxazolam versus chlorprothixene.
    Laux G, Koenig W, Pfaff G.
    Pharmacopsychiatry; 1988 Mar 01; 21(2):87-92. PubMed ID: 2899329
    [Abstract] [Full Text] [Related]

  • 13. Relative speed of onset of the antidepressant effect of maprotiline.
    Silverstone T.
    Clin Ther; 1981 Mar 01; 3(5):374-81. PubMed ID: 7471133
    [Abstract] [Full Text] [Related]

  • 14. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
    Bender S, Olbrich HM, Fischer W, Hornstein C, Schoene W, Falkai P, Haarmann C, Berger M, Gastpar M, Trimipramine Study Group.
    Pharmacopsychiatry; 2003 Mar 01; 36(2):61-9. PubMed ID: 12734763
    [Abstract] [Full Text] [Related]

  • 15. Response of negative symptoms of schizophrenia to neuroleptic treatment.
    Serban G, Siegel S, Gaffney M.
    J Clin Psychiatry; 1992 Jul 01; 53(7):229-34. PubMed ID: 1639741
    [Abstract] [Full Text] [Related]

  • 16. A single-blind study of clocapramine and sulpiride in hospitalized chronic schizophrenic patients.
    Yamagami S, Kiriike N, Kawaguchi K.
    Drugs Exp Clin Res; 1988 Jul 01; 14(11):707-13. PubMed ID: 3246215
    [Abstract] [Full Text] [Related]

  • 17. Low-dose zotepine in the maintenance treatment of schizophrenia.
    Fleischhacker WW, Stuppäck C, Barnas C, Unterweger B, Hinterhuber H.
    Pharmacopsychiatry; 1987 Feb 01; 20(1 Spec No):61-3. PubMed ID: 2883685
    [Abstract] [Full Text] [Related]

  • 18. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP, Spina E, Murray S, Yang R.
    Int Clin Psychopharmacol; 2006 May 01; 21(3):143-51. PubMed ID: 16528136
    [Abstract] [Full Text] [Related]

  • 19. [Positive and negative symptoms in chronic schizophrenic patients under maintenance therapy with flupenthixol decanoate for a twelve month perioid].
    Pach J, Finkbeiner T, Glaser T, Haug J, Osterheider M, Tegeler J.
    Fortschr Neurol Psychiatr; 1998 Oct 01; 66(10):442-9. PubMed ID: 9825249
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
    Gwirtsman HE, Ahles S, Halaris A, DeMet E, Hill MA.
    J Clin Psychiatry; 1983 Dec 01; 44(12):449-53. PubMed ID: 6361005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.